Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Idexx Laboratories Inc. buy BNP Paribas

Start price
€486.40
07.12.23 / 50%
Target price
€557.75
07.12.24
Performance (%)
-4.05%
Price
€466.70
26.04.24
Summary
This prediction is currently active. With a performance of -4.05%, the BUY prediction by BNP_Paribas is trending in the wrong direction. This prediction currently runs until 07.12.24. The prediction end date can be changed by BNP_Paribas at any time. BNP_Paribas has 50% into this prediction

IDEXX Laboratories, Inc. (Symbol: IDXX) is a leading global developer, manufacturer, and distributor of veterinary diagnostic and information technology products and services, primarily catering to companion animal healthcare, livestock and poultry, water testing, and dairy. The company operates through various segments including Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy, and Other Veterinary Businesses. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Labs continues to innovate and grow, driven by a strong commitment to scientific innovation, customer service, and overall animal health and well-being. With a wide range of diagnostic products, software solutions, and connected services, IDXX plays a significant role in the veterinary care industry and serves customers across more than 175 countries.

Performance without dividends (%)
Name 1w 1m
Idexx Laboratories Inc. 4.384% 4.384%
iShares Core DAX® 2.594% -1.861%
iShares Nasdaq 100 3.553% -2.064%
iShares Nikkei 225® 0.687% -8.704%
iShares S&P 500 2.209% -1.988%

Comments by BNP_Paribas for this prediction

In the thread Idexx Laboratories Inc. diskutieren
Prediction Buy
Perf. (%) -4.05%
Target price 557.753
Change
Ends at 07.12.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $602.00 price target on the stock.
Ratings data for IDXX provided by MarketBeat